[TimAlerts] The massive volume is from Twitter pumping another Icahn play but $ENZN is one of the top 4 biotechnology stocks on the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin is 92.30%. EPS for the same period is $0.65.